|
|
||||||||
Papers In Press, published online ahead of print December 1, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pharmacology Dept., Medical College of Wisconsin, Milwaukee, WI 53226
Corresponding Author: chillard{at}mcw.edu
N-Arachidonylethanolamine (AEA) accumulates during brain injury and post-mortem. Since fatty acid amide hydrolase (FAAH) regulates brain AEA content, the purpose of this study was to determine its role in the post-mortal accumulation of AEA using FAAH null mice. As expected, AEA content in immediately frozen brain tissue was significantly greater in FAAH-/- than wild type mice. However, AEA content was significantly lower in brains from FAAH-/- mice at 5 and 24 h post-mortem. Similarly, wild type mice treated in vivo with a FAAH inhibitor (URB532) had significantly lower brain AEA content 24 h post-mortem compared to controls. These data indicate that FAAH contributes significantly to the post-mortal accumulation of AEA. In contrast, the accumulation of two other N-acylethanolamines, oleoylethanolamide (OEA) and palmitoylethanolamide (PEA) were not reduced at 24 h post-mortem in either the FAAH-/- mice or in mice treated with URB532. FAAH-/- mice accumulated significantly less ethanolamine at 24 h post-mortem compared to wild-type mice, suggesting that FAAH activity plays a role in the accumulation of ethanolamine post-mortem. These data demonstrate that FAAH activity differentially affects AEA and OEA/PEA contents post-mortem and suggest that AEA formation specifically occurs via an ethanolamine-dependent route post-mortem.
Revised on November 17, 2004
Accepted on November 18, 2004
The post-mortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. Caille, L. Alvarez-Jaimes, I. Polis, D. G. Stouffer, and L. H. Parsons Specific Alterations of Extracellular Endocannabinoid Levels in the Nucleus Accumbens by Ethanol, Heroin, and Cocaine Self-Administration J. Neurosci., April 4, 2007; 27(14): 3695 - 3702. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. Muccioli, C. Xu, E. Odah, E. Cudaback, J. A. Cisneros, D. M. Lambert, M. L. Lopez Rodriguez, S. Bajjalieh, and N. Stella Identification of a Novel Endocannabinoid-Hydrolyzing Enzyme Expressed by Microglial Cells J. Neurosci., March 14, 2007; 27(11): 2883 - 2889. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Lombardi, G. Miglio, F. Varsaldi, A. Minassi, and G. Appendino Oxyhomologation of the Amide Bond Potentiates Neuroprotective Effects of the Endolipid N-Palmitoylethanolamine J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 599 - 606. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Patel and C. J. Hillard Pharmacological Evaluation of Cannabinoid Receptor Ligands in a Mouse Model of Anxiety: Further Evidence for an Anxiolytic Role for Endogenous Cannabinoid Signaling J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 304 - 311. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |